Rilpivirine dimethyl

Rilpivirine dimethyl is a process-related impurity formed via methylation at the pyridine nitrogen and a quinoline carbon, introducing two methyl substituents that disrupt the parent drug's hydrogen bonding and electronic distribution. This derivative retains the 4-(cyclopropylmethoxy)quinoline core but exhibits altered lipophilicity and reduced tautomeric flexibility due to N-methylation. The dimethyl substitution pattern creates a distinct mass spectral fingerprint, enabling differentiation from degradation products. It functions as an HPLC reference standard for quantifying synthetic byproducts in Rilpivirine API manufacturing.